Grindr Inc. — Form 8-K Summary
Event date: September 30, 2026. This is a current report announcing a proposed acquisition, not a quarterly or annual earnings report.
Business context and transaction terms
Grindr and its wholly owned Canadian subsidiary agreed to acquire all outstanding shares of PurposeMed Inc., the parent of Freddie, a telehealth provider of PrEP and HIV prevention care, including partnerships with affiliated clinical networks. The transaction has not yet closed.
- Base purchase price: $250 million, comprising $190 million in cash and $60 million in Grindr common stock.
- Stock consideration: 3,851,684 shares, valued at $15.58 per share using the 15-trading-day volume-weighted average price through September 29, 2026. The shares will be subject to a 12-month lock-up after closing.
- Additional consideration: up to $70 million in cash, contingent on PurposeMed achieving specified fiscal 2027 financial targets; any earned amount is payable after the applicable measurement period.
Financial metrics and comparison
The filing provides no transaction financing details beyond the stated cash and stock consideration, and no Grindr or PurposeMed revenue, profit, cash flow, margin, debt, or liquidity figures. It does not provide comparable-period financial results or quantify expected synergies, accretion, or dilution beyond the number of shares to be issued.
Conditions, risks, and outlook
Closing is subject to customary conditions, including representations and covenant compliance, no material adverse effect on PurposeMed, no legal prohibition, completion of a pre-closing restructuring, and NYSE listing approval for the shares. Either the buyer or the sellers’ representative may terminate if closing has not occurred by December 30, 2026, subject to the agreement’s terms.
The buyer obtained representations and warranties insurance, which, together with the sellers’ portion of the retention, is the buyer’s sole recourse for covered breaches of PurposeMed’s and the sellers’ representations and warranties. Certain sellers separately agreed to indemnify Grindr and the buyer for specified liabilities, subject to limitations. Grindr guaranteed the buyer’s obligations.
The shares are to be issued in reliance on the Securities Act Section 4(a)(2) exemption. The filing does not include management’s detailed outlook or operating commentary; it identifies a press release and shareholder letter as exhibits, but their contents are not included in the supplied text.
Key facts for investors to verify
- Whether and when the required closing conditions are satisfied, including the restructuring and NYSE listing approval.
- PurposeMed’s financial performance and the specific fiscal 2027 earnout targets and measurement terms in the full purchase agreement.
- The final cash funding source, any impact on Grindr’s liquidity or debt, and the transaction’s expected financial contribution.
- The share issuance at closing, resulting dilution, lock-up terms, and any updates to the transaction timeline or purchase consideration.
- The full purchase agreement and the September 30, 2026 press release and shareholder letter, which may provide additional terms or management commentary.